Spry NA - Search Results

1

Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.

Galvão DA, Spry NA, Taaffe DR, Newton RU, Stanley J, Shannon T, Rowling C, Prince R. Galvão DA, et al. Among authors: spry na. BJU Int. 2008 Jul;102(1):44-7. doi: 10.1111/j.1464-410X.2008.07539.x. Epub 2008 Mar 11. BJU Int. 2008. PMID: 18336606

2

Resistance training and reduction of treatment side effects in prostate cancer patients.

Galvão DA, Nosaka K, Taaffe DR, Spry N, Kristjanson LJ, McGuigan MR, Suzuki K, Yamaya K, Newton RU. Galvão DA, et al. Med Sci Sports Exerc. 2006 Dec;38(12):2045-52. doi: 10.1249/01.mss.0000233803.48691.8b. Med Sci Sports Exerc. 2006. PMID: 17146309 Clinical Trial.

3

International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients.

Shaw GL, Wilson P, Cuzick J, Prowse DM, Goldenberg SL, Spry NA, Oliver T. Shaw GL, et al. Among authors: spry na. BJU Int. 2007 May;99(5):1056-65. doi: 10.1111/j.1464-410X.2007.06770.x. Epub 2007 Mar 6. BJU Int. 2007. PMID: 17346277 Review.

4

Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer.

Galvão DA, Taaffe DR, Spry N, Newton RU. Galvão DA, et al. Prostate Cancer Prostatic Dis. 2007;10(4):340-6. doi: 10.1038/sj.pcan.4500975. Epub 2007 May 8. Prostate Cancer Prostatic Dis. 2007. PMID: 17486110 Review.

5

Endocrine and immune responses to resistance training in prostate cancer patients.

Galvão DA, Nosaka K, Taaffe DR, Peake J, Spry N, Suzuki K, Yamaya K, McGuigan MR, Kristjanson LJ, Newton RU. Galvão DA, et al. Prostate Cancer Prostatic Dis. 2008;11(2):160-5. doi: 10.1038/sj.pcan.4500991. Epub 2007 Jul 17. Prostate Cancer Prostatic Dis. 2008. PMID: 17637762

6

Can exercise ameliorate the increased risk of cardiovascular disease and diabetes associated with ADT?

Galvão DA, Newton RU, Taaffe DR, Spry N. Galvão DA, et al. Nat Clin Pract Urol. 2008 Jun;5(6):306-7. doi: 10.1038/ncpuro1104. Epub 2008 Apr 22. Nat Clin Pract Urol. 2008. PMID: 18431358 Review. No abstract available.

7

Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation.

Galvão DA, Taaffe DR, Spry N, Joseph D, Turner D, Newton RU. Galvão DA, et al. Prostate Cancer Prostatic Dis. 2009;12(2):198-203. doi: 10.1038/pcan.2008.51. Epub 2008 Oct 14. Prostate Cancer Prostatic Dis. 2009. PMID: 18852703 Clinical Trial.

8

Long-term effects of intermittent androgen suppression on testosterone recovery and bone mineral density: results of a 33-month observational study.

Spry NA, Galvão DA, Davies R, La Bianca S, Joseph D, Davidson A, Prince R. Spry NA, et al. BJU Int. 2009 Sep;104(6):806-12. doi: 10.1111/j.1464-410X.2009.08458.x. Epub 2009 Mar 5. BJU Int. 2009. PMID: 19281463 Clinical Trial.

9

Cardiovascular and metabolic complications during androgen deprivation: exercise as a potential countermeasure.

Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU. Galvão DA, et al. Prostate Cancer Prostatic Dis. 2009;12(3):233-40. doi: 10.1038/pcan.2009.12. Epub 2009 Jun 2. Prostate Cancer Prostatic Dis. 2009. PMID: 19488067 Review.

10

A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.

Newton RU, Taaffe DR, Spry N, Gardiner RA, Levin G, Wall B, Joseph D, Chambers SK, Galvão DA. Newton RU, et al. BMC Cancer. 2009 Jun 29;9:210. doi: 10.1186/1471-2407-9-210. BMC Cancer. 2009. PMID: 19563641 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters